Presenting on the above topic is Dr Berthold Bodeke, Chief Scientist,Head Cell Culture & Pilot Plants, Bayer Pharmaceuticals, Germany. He will be speaking at Biologic Manufacturing World Asia 2012, part of a series of conferences in the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore.
Dr. Berthold BÃ¶deker is Chief Scientist and heading pilot plants and cell culture at the CMC unit of Global Drug Discovery-Biological Development of Bayer Schering Pharma AG in Wuppertal, Germany, which is responsible for the technical development and clinical material production of microbial and mammalian proteins. Before that he held several positions in research, development and production of proteins from mammalian cell culture within the Bayer AG group. Among others he was responsible for the technical development and manufacturing of recombinant factor VIII, KogenateÂ®, the first world-wide licensed recombinant protein from continuous perfusion culture. In addition he is also responsible for contract development and production of Biologics for external clients as well as acts as manager for outsourced development projects.
Dr Boedeker will be presenting on the following topics:
Optimising your biologic manufacturing operations through single-use technologies application
1. Understanding regulatory compliance aspects of single use technologies
2. Practical applications of single use technologies for suspension cell cultures
3. Comparing hard-pided versus disposable-based facility design and operation options in the present context of 2-5g/L expression rates